PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)
|
disease |
|
Finding
|
1
|
2
|
0.400 |
None |
|
0 |
2
|
|
|
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.300 |
None |
|
0 |
|
|
|
Excessive bleeding from superficial cuts
|
phenotype |
|
Pathologic Function
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Impaired platelet aggregation
|
phenotype |
|
Finding
|
16
|
|
0.100 |
None |
|
0 |
|
|
|
Subcutaneous hemorrhage
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
16
|
|
0.100 |
None |
|
0 |
|
|
|
Anaplastic Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
1
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Cellular Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
7
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Papillary ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Myxopapillary ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
12
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Central Nervous System Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
180
|
72
|
0.110 |
None |
1.000 |
1 |
|
2012 |
2012 |
Thyroxine measurement
|
phenotype |
|
Laboratory Procedure
|
24
|
42
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Triiodothyronine measurement
|
phenotype |
|
Laboratory Procedure
|
6
|
12
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Multiple polyps
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
77
|
32
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Intestinal metaplasia
|
phenotype |
|
Disease or Syndrome
|
266
|
24
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Arteriovenous hemangioma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
76
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pleomorphic Xanthoastrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
42
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Acute panmyelosis with myelofibrosis
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Optic Atrophy 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
117
|
45
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Endometriosis of uterus
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
154
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Intrahepatic Cholangiocarcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
470
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperplastic Polyp
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
204
|
22
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
High-Grade Squamous Intraepithelial Lesions
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
150
|
8
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Ependymoma
|
disease |
Neoplasms
|
Neoplastic Process
|
144
|
3
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Childhood Burkitt Lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
477
|
7
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Malignant Bone Neoplasm
|
disease |
Neoplasms; Musculoskeletal Diseases
|
Neoplastic Process
|
125
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |